Loading
Latest filing published 18 Jun 2026 for enGene Therapeutics Inc.. Read the official filing
No signal scores available.
William Grossman appears in our data through filings on enGene Therapeutics Inc. shares, published by SEDI. Altogether 2 filings, all relating to 16 June 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 18 June 2026, the filings show an option exercise in enGene Therapeutics Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations